Effect of poly(vinylsulfonate) on murine AA amyloid: A high-resolution ultrastructural study

Laboratory Investigation

Volumn 74, Issue 6, 1996, Pages 1081-1090

  Inoue, Sadayuki ^a   Hultin, Philip G ^b   Szarek, Walter A ^b   Kisilevsky, Robert ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; AMYLOID P COMPONENT; POLY(VINYLSULFONATE SODIUM); PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL ULTRASTRUCTURE; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; CONTROLLED STUDY; FEMALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING;

AMYLOIDOSIS; ANIMALS; FEMALE; MICE; MICE, INBRED STRAINS; POLYVINYLS; SERUM AMYLOID A PROTEIN; SPLEEN; SULFONIC ACIDS;

EID: 0030009884     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ailles L, Kisilevsky R, and Young ID (1993). Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. Lab Invest 69: 443-448.
2. Baltz ML, Caspi D, Hind CRK, Feinstein A, and Pepys MB (1986). Isolation and characterization of amyloid enhancing factor (AEF). In: Glenner GG, Osserman EF, Benditt EP, Calkins E, Cohen AS, and Zucker-Franklin D, editors. Amyloidosis. New York: Plenum Press, 115-121.
3. Caughey B (1993). Scrapie-associated PrP accumulation and its prevention: Insights from cell culture. Br Med Bull 49:860-872.
4. Caughey B (1994a). Protease-resistant PrP accumulation and scrapie agent replication: A role for sulphated glycosaminoglycans. Biochem Soc Trans 22:163-167.
5. Caughey B (1994b). Scrapie-associated PrP accumulation and agent replication: Effects of sulphated glycosaminoglycan analogues. Philos Trans R Soc Lond [Biol] 343:399-404.
6. Caughey B and Race RE (1992). Potent inhibition of scrapie-associated PrP accumulation by Congo red. J Neurochem 59:768-771.
7. Caughey B and Race RE (1994). Scrapie-associated PrP accumulation and its inhibition: Revisiting the amyloid-glycosaminoglycan connection. Ann N Y Acad Sci 724:290-295.
8. Caughey B and Raymond GJ (1993). Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67:643-650.
9. De Beer MC, De Beer FC, McCubbin WD, Kay CM, and Kindy MS (1993). Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 268:20606-20612.
10. Eldred WD, Zucker C, Karten HJ, and Yazulla S (1983). Comparison of fixation and penetration enhancement techniques for use in ultrastructural immunocytochemistry. J Histochem Cytochem 31:285-292.
11. Gupta-Bansal R, Frederickson RCA, and Brunden KR (1995). Proteoglycan-mediated inhibition of A beta proteolysis: A potential cause of senile plaque accumulation. J Biol Chem 270:18666-18671.
12. Gupta-Bansal R, Ziehler W, Wujek JR, and Brunden KR (1993). Potential role of proteoglycans in the accumulation and persistence of beta-amyloid (Aβ) in Alzheimer's disease (AD) senile plaques. Neurosci Abstr 600.5:1471.
13. Hoffman JS, Ericsson LH, Eriksen N, Walsh KA, and Benditt EP (1984). Murine tissue amyloid protein AA: NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med 159:641-646.
14. Inoue S (1991). Pentosome - a new connective tissue component - is a subunit of amyloid-P. Cell Tissue Res 263:431-438.
15. Inoue S (1995a). Ultrastructural organization of connective tissue microfibrils in the posterior chamber of the eye in vivo and in vitro. Cell Tissue Res 279:291-302.
16. Inoue S (1995b). Association of malachite green-positive material with heparan sulfate proteoglycan double tracks in basement membrane of mouse kidney tubules. J Histochem Cytochem 43:293-297.
17. Inoue S (1995c). Ultrastructural and immunohistochemical studies of microfibril-associated components in the posterior chamber of the eye. Cell Tissue Res 279:303-313.
18. Inoue S, Grant D, and Leblond CP (1989). Heparan sulfate proteoglycan is present in basement membrane as a double-tracked structure. J Histochem Cytochem 37:597-602.
19. Inoue S and Kisilevsky R (1996). A high resolution ultrastructural study of experimental murine AA amyloid. Lab Invest 74:670-683.
20. Inoue S, Leblond CP, Grant DS, and Rico P (1986). The microfibrils of connective tissue. II. Immunohistochemical detection of the amyloid P component. Am J Anat 176:139.
21. Kisilevsky R, Gruys E, and Shirahama T (1995a). Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity? Amyloid 2:128-133.
22. Kisilevsky R, Lemieux LJ, Fraser PE, Kong XQ, Hultin PG, and Szarek WA. (1995b). Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer's disease. Nat Med 1:143-148.
23. Kisilevsky R, Narindrasorasak S, Tape C, Tan R, and Boudreau L (1994). During AA amyloidogenesis is proteolytic attack on serum amyloid A a pre- or post-fibrillogenic event? Amyloid 1:174-183.
24. Kisilevsky R and Young ID (1994). Pathogenesis of amyloidosis. In: Husby G, editor. Clinical rheumatology: Reactive amyloidosis and the acute phase response, vol 8. London: Bailliere Tindall, 613-626.
25. Kushner I and Rzewnicki DL (1994). The acute phase respose: General aspects. In: Husby G, editor. Clinical rheumatology: Reactive amyloidosis and the acute phase response, vol 8. London: Bailliere Tindall, 513-530.
26. Laurie GW, Inoue S, Bing JT, and Hassell JR (1988). Visualization of the large heparan sulfate proteoglycan from basement membrane. Am J Anat 181:320-326.
27. Leveugle B, Scanameo A, Ding W, and Fillit H (1994). Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: Inhibition by potentially therapeutic polysulfated compounds. Neuroreport 5:1389-1392.
28. Lorenzo A and Yankner BA (1994). Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91:12243-12247.
29. Lyon AW, Narindrasorasak S, Young ID, Anastassiades T, Couchman JR, McCarthy K, and Kisilevsky R (1991). Co-deposition of basement membrane components during the induction of murine splenic AA amyloid. Lab Invest 64:785-790.
30. McCubbin WD, Kay CM, Narindrasorasak S, and Kisilevsky R (1988). Circular dichroism and fluorescence studies on two murine serum amyloid A proteins. Biochem J 256:775-783.
31. Meek RL, Hoffman JS, and Benditt EP (1986). Amyloidogenesis: One serum amyloid A isotype is selectively removed from the circulation. J Exp Med 163:499-510.
32. Pollack SJ, Sadler IIJ, Hawtin SR, Tailor VJ, and Shearman MS (1995). Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci Lett 184:113-116.
33. Priola SA and Caughey B (1994). Inhibition of scrapie-associated PrP accumulation: Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol 8:113-120.
34. Puchtler H, Sweat F, and Levine M (1962). On the binding of Congo red by amyloid. J Histochem Cytochem 10:355-364.
35. Puchtler H, Waldrop FS, and Meloan SN (1983). Application of thiazole dyes to amyloid under conditions of direct cotton dyeing: Correlation of histochemical and chemical data. Histochemistry 77:431-445.
36. Snow AD, Bramson R, Mar H, Wight TN, and Kisilevsky R (1991). A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem 39:1321-1330.
37. Snow AD and Kisilevsky R (1988). A close ultrastructural relationship between sulphated proteoglycans and AA amyloid fibrils. Lab Invest 57:687-698.
38. Snow AD, Kisilevsky R, Stephens C, and Anastassiades T (1987). Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation: Quantitative and qualitative analysis. Lab Invest 56:665-675.